| JYHZ2100559 | 沙格列汀二甲双胍缓释片（Ⅲ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHZ2100558 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHZ2100557 | 沙格列汀二甲双胍缓释片（Ⅰ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHZ2100556 | 沙格列汀二甲双胍缓释片（Ⅲ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHZ2100555 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHZ2100554 | 沙格列汀二甲双胍缓释片（Ⅰ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | License Renew | 2021-06-09 | | | | | view |
| JYHZ2000129 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2020-05-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-12-09 | view |
| JYHZ2000128 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2020-05-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-12-09 | view |
| JYHZ2000127 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2020-05-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-12-09 | view |
| JYHZ2000126 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | License Renew | 2020-05-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-12-09 | view |
| JYHF2100004 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Supplementary Application | 2021-01-16 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2021-01-22 | view |
| JYHF2100003 | 沙格列汀片 | Saxagliptin | Tablet | Chemical Drugs | Supplementary Application | 2021-01-16 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2021-01-22 | view |
| JYHF1700057 | 沙格列汀二甲双胍缓释片(II) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-22 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Certificate Issued | 2017-08-01 | view |
| JYHF1700056 | 沙格列汀二甲双胍缓释片(I) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-22 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | In Review | 2018-02-13 | view |
| JYHF1700055 | 沙格列汀二甲双胍缓释片(III) | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2017-06-22 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Certificate Issued | 2017-08-01 | view |
| JYHB2300378 | 沙格列汀二甲双胍缓释片（Ⅲ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2023-07-08 | | | | | view |
| JYHB2300377 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2023-07-08 | | | | | view |
| JYHB2300376 | 沙格列汀二甲双胍缓释片（Ⅰ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2023-07-08 | | | | | view |
| JYHB2300375 | 沙格列汀二甲双胍缓释片（Ⅲ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2023-07-08 | | | | | view |
| JYHB2300374 | 沙格列汀二甲双胍缓释片（Ⅱ） | metformin hydrochloride;saxagliptin | Tablet, extended release | Chemical Drugs | Supplementary Application | 2023-07-08 | | | | | view |
